本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2024/10/101 分钟阅读
Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program Final Guidance
本地自动翻译 · 来源原始语言
摘要
The Centers for Medicare & Medicaid Services (CMS) is announcing the availability of CMS' final guidance for the second cycle of the Medicare Drug Price Negotiation Program and manufacturer effectuation of the maximum fair price in 2026 and 2027 for the implementation of the Inflation Reduction Act. This and other Inflation Reduction Act-related guidance can be viewed on the dedicated Inflation Reduction Act section of the CMS website at https://www.cms.gov/ inflation-reduction-act-and-medicare/.
来源原始语言: Federal Register — Health and Human Services打开原始公告 →